$331.41
$0.00 (0.00%)
End-of-day quote: 05/31/2024
NYSE:WST

West Pharmaceutical Services Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$2.95B $2.89B $2.83B $2.15B $1.84B $1.72B $1.60B $1.51B $1.40B $1.42B $1.37B $1.27B $1.19B $1.10B $1.06B $1.05B $1.02B $913.30M $699.70M $541.60M
GM % Gross Margin %
38.31% 39.36% 41.59% 35.76% 32.92% 31.76% 32.07% 33.23% 32.56% 31.50% 31.77% 30.61% 28.46% 28.80% 28.76% 28.79% 28.61% 28.99% 28.08% 29.01%
OM Operating Margin
24.09% 26.46% 27.08% 19.57% 16.09% 14.61% 14.96% 15.17% 9.29% 12.90% 11.97% 11.28% 9.99% 9.64% 10.23% 11.85% 11.08% 11.57% 10.50% 9.88%
EPS Earnings Per Share
$0.00 $8.08 $8.58 $8.58 $4.76 $3.24 $2.81 $2.78 $2.18 $1.83 $1.78 $1.63 $1.38 $1.17 $1.05 $1.06 $1.19 $1.19 $1.00 $0.72 $0.67
Div. Dividends
$0.78 $0.74 $0.69 $0.66 $0.61 $0.57 $0.53 $0.49 $0.45 $0.41 $0.39 $0.00 $0.35 $0.33 $0.31 $0.29 $0.27 $0.00 $0.00 $0.00
PR % Payout Ratio %
9.65% 8.62% 8.04% 13.87% 18.83% 20.28% 19.06% 22.48% 24.59% 23.03% 23.93% 0 29.91% 31.43% 29.25% 24.37% 22.69% 0 0 0
Sha. Shares
73.5m 74.1m 74.2m 74.02m 74.1m 74.1m 73.9m 73.1m 72.3m 71.3m 70.2m 68.6m 67.4m 66.6m 66m 65.4m 64.6m 65.8m 63.4m 61.42m
OCF Operating Cash Flow
$776.50M $724.00M $584.00M $472.50M $367.20M $288.60M $263.30M $219.40M $212.40M $182.90M $220.50M $187.40M $130.70M $138.30M $137.70M $135.00M $129.20M $143.80M $79.80M $69.10M
FCF Free Cash Flow
$358.30M $439.40M $330.60M $298.10M $240.80M $183.90M $132.50M $49.20M $80.80M $71.00M $68.60M $56.10M $35.30M $67.20M $32.80M $-3.60M $-0.20M $53.50M $25.70M $11.70M
FCFS Free Cash Flow Per Share
$5.58 $5.91 $4.44 $4.03 $3.25 $2.49 $1.79 $0.67 $1.12 $1.00 $0.93 $0.81 $0.50 $0.97 $0.46 $-0.06 $-0.07 $0.83 $0.41 $0.20